These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30178007)

  • 21. Diagnosis of tuberculosis from smear-negative presumptive TB cases using Xpert MTB/Rif assay: a cross-sectional study from Nepal.
    Khadka P; Thapaliya J; Basnet RB; Ghimire GR; Amatya J; Rijal BP
    BMC Infect Dis; 2019 Dec; 19(1):1090. PubMed ID: 31888522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the GeneXpert MTB/RIF assay on extrapulmonary and respiratory samples other than sputum: a low burden country experience.
    Pandey S; Congdon J; McInnes B; Pop A; Coulter C
    Pathology; 2017 Jan; 49(1):70-74. PubMed ID: 27913043
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Xpert MTB/RIF assay for diagnosis of pulmonary tuberculosis in children: a prospective, multi-centre evaluation.
    Reither K; Manyama C; Clowes P; Rachow A; Mapamba D; Steiner A; Ross A; Mfinanga E; Sasamalo M; Nsubuga M; Aloi F; Cirillo D; Jugheli L; Lwilla F
    J Infect; 2015 Apr; 70(4):392-9. PubMed ID: 25312863
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing.
    Peter J; Theron G; Chanda D; Clowes P; Rachow A; Lesosky M; Hoelscher M; Mwaba P; Pym A; Dheda K;
    BMC Infect Dis; 2015 Jul; 15():262. PubMed ID: 26156025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DIAGNOSTIC TEST OF SPUTUM GENEXPERT MTB/RIF FOR SMEAR NEGATIVE PULMONARY TUBERCULOSIS.
    Reechaipichitkul W; Phetsuriyawong A; Chaimanee P; Ananta P
    Southeast Asian J Trop Med Public Health; 2016 May; 47(3):457-66. PubMed ID: 27405129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of Xpert MTB/RIF Ultra performance for pulmonary tuberculosis diagnosis on smear-negative respiratory samples in a French centre.
    Hodille E; Maisson A; Charlet L; Bauduin C; Genestet C; Fredenucci I; Rasigade JP; Lina G; Dumitrescu O
    Eur J Clin Microbiol Infect Dis; 2019 Mar; 38(3):601-605. PubMed ID: 30680567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid diagnosis of pulmonary tuberculosis in African children in a primary care setting by use of Xpert MTB/RIF on respiratory specimens: a prospective study.
    Zar HJ; Workman L; Isaacs W; Dheda K; Zemanay W; Nicol MP
    Lancet Glob Health; 2013 Aug; 1(2):e97-e104. PubMed ID: 25104164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance evaluation of Xpert MTB/RIF in a moderate tuberculosis incidence compared with TaqMan MTB and TRCRapid M.TB.
    Tsuyuguchi K; Nagai H; Ogawa K; Matsumoto T; Morimoto K; Takaki A; Mitarai S
    J Infect Chemother; 2017 Feb; 23(2):101-106. PubMed ID: 27919693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of Xpert® MTB/RIF Assay in Induced Sputum and Gastric Lavage Samples from Young Children with Suspected Tuberculosis from the MVA85A TB Vaccine Trial.
    Bunyasi EW; Tameris M; Geldenhuys H; Schmidt BM; Luabeya AK; Mulenga H; Scriba TJ; Hanekom WA; Mahomed H; McShane H; Hatherill M
    PLoS One; 2015; 10(11):e0141623. PubMed ID: 26554383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incremental yield and cost of urine Determine TB-LAM and sputum induction in seriously ill adults with HIV.
    Boyles TH; Griesel R; Stewart A; Mendelson M; Maartens G
    Int J Infect Dis; 2018 Oct; 75():67-73. PubMed ID: 30125689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Xpert MTB/RIF assay can be used on archived gastric aspirate and induced sputum samples for sensitive diagnosis of paediatric tuberculosis.
    Singh S; Singh A; Prajapati S; Kabra SK; Lodha R; Mukherjee A; Singh V; Hesseling AC; Grewal HM;
    BMC Microbiol; 2015 Sep; 15():191. PubMed ID: 26420261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use and efficacy of tuberculosis infection control practices at hospitals with previous outbreaks of multidrug-resistant tuberculosis.
    Tokars JI; McKinley GF; Otten J; Woodley C; Sordillo EM; Caldwell J; Liss CM; Gilligan ME; Diem L; Onorato IM; Jarvis WR
    Infect Control Hosp Epidemiol; 2001 Jul; 22(7):449-55. PubMed ID: 11583215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feasibility of a streamlined tuberculosis diagnosis and treatment initiation strategy.
    Shete PB; Nalugwa T; Farr K; Ojok C; Nantale M; Howlett P; Haguma P; Ochom E; Mugabe F; Joloba M; Chaisson LH; Dowdy DW; Moore D; Davis JL; Katamba A; Cattamanchi A
    Int J Tuberc Lung Dis; 2017 Jul; 21(7):746-752. PubMed ID: 28633698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis of smear-negative tuberculosis is greatly improved by Xpert MTB/RIF.
    Lombardi G; Di Gregori V; Girometti N; Tadolini M; Bisognin F; Dal Monte P
    PLoS One; 2017; 12(4):e0176186. PubMed ID: 28430807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipoarabinomannan in sputum to detect bacterial load and treatment response in patients with pulmonary tuberculosis: Analytic validation and evaluation in two cohorts.
    Kawasaki M; Echiverri C; Raymond L; Cadena E; Reside E; Gler MT; Oda T; Ito R; Higashiyama R; Katsuragi K; Liu Y
    PLoS Med; 2019 Apr; 16(4):e1002780. PubMed ID: 30978194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study protocol: a cluster randomized trial to evaluate the effectiveness and implementation of onsite GeneXpert testing at community health centers in Uganda (XPEL-TB).
    Reza TF; Nalugwa T; Farr K; Nantale M; Oyuku D; Nakaweesa A; Musinguzi J; Vangala M; Shete PB; Tucker A; Ferguson O; Fielding K; Sohn H; Dowdy D; Moore DAJ; Davis JL; Ackerman SL; Handley MA; Katamba A; Cattamanchi A
    Implement Sci; 2020 Apr; 15(1):24. PubMed ID: 32316993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Performance of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis and rifampin resistance in a low-incidence, high-resource setting.
    Rice JP; Seifert M; Moser KS; Rodwell TC
    PLoS One; 2017; 12(10):e0186139. PubMed ID: 29016684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Added value of molecular assay Xpert MTB/RIF compared to sputum smear microscopy to assess the risk of tuberculosis transmission in a low-prevalence country.
    Opota O; Senn L; Prod'hom G; Mazza-Stalder J; Tissot F; Greub G; Jaton K
    Clin Microbiol Infect; 2016 Jul; 22(7):613-9. PubMed ID: 27139592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reassessment of the positive predictive value and specificity of Xpert MTB/RIF: a diagnostic accuracy study in the context of community-wide screening for tuberculosis.
    Ho J; Nguyen PTB; Nguyen TA; Tran KH; Van Nguyen S; Nguyen NV; Nguyen HB; Luu KB; Fox GJ; Marks GB
    Lancet Infect Dis; 2016 Sep; 16(9):1045-1051. PubMed ID: 27289387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Xpert MTB/RIF diagnosis of childhood tuberculosis from sputum and stool samples in a high TB-HIV-prevalent setting.
    Orikiriza P; Nansumba M; Nyehangane D; Bastard M; Mugisha IT; Nansera D; Mwanga-Amumpaire J; Boum Y; Kumbakumba E; Bonnet M
    Eur J Clin Microbiol Infect Dis; 2018 Aug; 37(8):1465-1473. PubMed ID: 29740714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.